Why the study?
Do beta-blockers (propranolol or acebutolol) improve regional coronary blood flow and left ventricular function in conscious dogs with myocardial ischemia?
Do beta-blockers (propranolol or acebutolol) improve regional coronary blood flow and left ventricular function in conscious dogs with myocardial ischemia?
Propranolol and acebutolol increase coronary flow to ischemic areas and reduce myocardial oxygen consumption in a canine model of myocardial infarction.
Supports beta-blocker flow redistribution in canine ischemia; leaves open translation to human management.
1 The cardiovascular effects of the beta-adrenoceptor blocking drugs, propranolol and acebutolol, on regional coronary blood flow and left ventricular function have been investigated in the conscious dog with developing myocardial infarction. 2 Propranolol (1 to 1.5 mg/kg) or acebutolol (4 to 5 mg/kg) were administered intravenously 2 to 3 h after occlusion of the left anterior descending coronary artery. 3 Propranolol or acebutolol administration resulted in a relative increase in flow to the ischaemic area of the myocardium, particularly to the subendocardium. 4 Propranolol produced a greater reduction in heart rate and myocardial contractility than acebutolol. 5 These results demonstrate that beta-adrenoceptor blocking drugs reduce myocardial oxygen consumption and increase coronary flow to the ischaemic area of the myocardium after coronary artery occlusion in the conscious dog.
No takes yet. Share an insight, caveat, or question.
Hillis et al. (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: